Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration

Cell Reports

Volumn 10, Issue 7, 2015, Pages 1040-1054

  Song, Jian ^a   Wu, Chuan ^a   Korpos, Eva ^a   Zhang, Xueli ^a   Agrawal, Smriti M ^a   Wang, Ying ^a   Faber, Cornelius ^a   Schäfers, Michael ^a   Körner, Heinrich ^b   Opdenakker, Ghislain ^c   Hallmann, Rupert ^a   Sorokin, Lydia ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF TASMANIA   (Australia)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GELATINASE A; GELATINASE B; GAMMA INTERFERON; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LEUKOCYTE MIGRATION; MOUSE; NEWBORN; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LEUKOCYTE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CELL MOVEMENT; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CHEMOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON-GAMMA; INTERLEUKIN-17; LEUKOCYTES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924623154     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.01.037     Document Type: Article

References (45)

1. Agrawal S., Anderson P., Durbeej M., van Rooijen N., Ivars F., Opdenakker G., Sorokin L.M. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J.Exp. Med. 2006, 203:1007-1019.
2. Ambrosini E., Remoli M.E., Giacomini E., Rosicarelli B., Serafini B., Lande R., Aloisi F., Coccia E.M. Astrocytes produce dendritic cell-attracting chemokines invitro and in multiple sclerosis lesions. J.Neuropathol. Exp. Neurol. 2005, 64:706-715.
3. Carter S.L., Müller M., Manders P.M., Campbell I.L. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia invitro. Glia 2007, 55:1728-1739.
4. Cau E., Blader P. Notch activity in the nervous system: to switch or not switch?. Neural Dev. 2009, 4:36-47.
5. Corry D.B., Rishi K., Kanellis J., Kiss A., Song Lz L.Z., Xu J., Feng L., Werb Z., Kheradmand F. Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat. Immunol. 2002, 3:347-353.
6. De La Luz Sierra M., Yang F., Narazaki M., Salvucci O., Davis D., Yarchoan R., Zhang H.H., Fales H., Tosato G. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 2004, 103:2452-2459.
7. Di Girolamo N., Indoh I., Jackson N., Wakefield D., McNeil H.P., Yan W., Geczy C., Arm J.P., Tedla N. Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J.Immunol. 2006, 177:2638-2650.
8. Dubois B., Masure S., Hurtenbach U., Paemen L., Heremans H., van den Oord J., Sciot R., Meinhardt T., Hämmerling G., Opdenakker G., Arnold B. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J.Clin. Invest. 1999, 104:1507-1515.
9. Engelhardt B. Molecular mechanisms involved in Tcell migration across the blood-brain barrier. J.Neural Transm. 2006, 113:477-485.
10. Frieser M., Nöckel H., Pausch F., Röder C., Hahn A., Deutzmann R., Sorokin L.M. Cloning of the mouse laminin alpha 4 cDNA. Expression in a subset of endothelium. Eur. J. Biochem. 1997, 246:727-735.
11. Garg P., Sarma D., Jeppsson S., Patel N.R., Gewirtz A.T., Merlin D., Sitaraman S.V. Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer. Cancer Res. 2010, 70:792-801.
12. Glabinski A.R., Tani M., Tuohy V.K., Tuthill R.J., Ransohoff R.M. Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav. Immun. 1995, 9:315-330.
13. Glabinski A.R., Bielecki B., Kolodziejski P., Han Y., Selmaj K., Ransohoff R.M. TNF-alpha microinjection upregulates chemokines and chemokine receptors in the central nervous system without inducing leukocyte infiltration. J.Interferon Cytokine Res. 2003, 23:457-466.
14. Glabinski A., Jalosinski M., Ransohoff R.M. Chemokines and chemokine receptors in inflammation of the CNS. Expert Rev. Clin. Immunol. 2005, 1:293-301.
15. Hartupee J., Liu C., Novotny M., Li X., Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization. J.Immunol. 2007, 179:4135-4141.
16. Ho H.H., Antoniv T.T., Ji J.D., Ivashkiv L.B. Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1. J.Immunol. 2008, 181:5089-5097.
17. Huang D., Han Y., Rani M.R., Glabinski A., Trebst C., Sørensen T., Tani M., Wang J., Chien P., O'Bryan S., et al. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol. Rev. 2000, 177:52-67.
18. Itoh T., Ikeda T., Gomi H., Nakao S., Suzuki T., Itohara S. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J.Biol. Chem. 1997, 272:22389-22392.
19. Kim R.Y., Hoffman A.S., Itoh N., Ao Y., Spence R., Sofroniew M.V., Voskuhl R.R. Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis. J.Neuroimmunol. 2014, 274:53-61.
20. Körner H., Riminton D.S., Strickland D.H., Lemckert F.A., Pollard J.D., Sedgwick J.D. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J.Exp. Med. 1997, 186:1585-1590.
21. Langenbach K.J., Rando T.A. Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve 2002, 26:644-653.
22. Matsumura S., Iwanaga S., Mochizuki S., Okamoto H., Ogawa S., Okada Y. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J.Clin. Invest. 2005, 115:599-609.
23. McCandless E.E., Wang Q., Woerner B.M., Harper J.M., Klein R.S. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J.Immunol. 2006, 177:8053-8064.
24. McQuibban G.A., Gong J.H., Tam E.M., McCulloch C.A., Clark-Lewis I., Overall C.M. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000, 289:1202-1206.
25. McQuibban G.A., Butler G.S., Gong J.H., Bendall L., Power C., Clark-Lewis I., Overall C.M. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J.Biol. Chem. 2001, 276:43503-43508.
26. McQuibban G.A., Gong J.H., Wong J.P., Wallace J.L., Clark-Lewis I., Overall C.M. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties invivo. Blood 2002, 100:1160-1167.
27. Meiron M., Zohar Y., Anunu R., Wildbaum G., Karin N. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory Tcells. J.Exp. Med. 2008, 205:2643-2655.
28. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., Cohn R.D., Ross-Barta S.E., Westra S., Williamson R.A., et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 2002, 418:422-425.
29. Murphy C.A., Hoek R.M., Wiekowski M.T., Lira S.A., Sedgwick J.D. Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain. J.Immunol. 2002, 169:7054-7062.
30. Ogata Y., Enghild J.J., Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J.Biol. Chem. 1992, 267:3581-3584.
31. Paul D., Ge S., Lemire Y., Jellison E.R., Serwanski D.R., Ruddle N.H., Pachter J.S. Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation. J.Neuroinflammation 2014, 11:10.
32. Quinones M.P., Kalkonde Y., Estrada C.A., Jimenez F., Ramirez R., Mahimainathan L., Mummidi S., Choudhury G.G., Martinez H., Adams L., et al. Role of astrocytes and chemokine systems in acute TNFalpha induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-kappaB and Akt. Mol. Cell. Neurosci. 2008, 37:96-109.
33. Radtke F., Wilson A., Stark G., Bauer M., van Meerwijk J., MacDonald H.R., Aguet M. Deficient Tcell fate specification in mice with an induced inactivation of Notch1. Immunity 1999, 10:547-558.
34. Ransohoff R.M. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 2009, 31:711-721.
35. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 2002, 39:279-291.
36. Sixt M., Engelhardt B., Pausch F., Hallmann R., Wendler O., Sorokin L.M. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in Tcell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J.Cell Biol. 2001, 153:933-946.
37. Thompson W.L., Van Eldik L.J. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected]. Brain Res. 2009, 1287:47-57.
38. Toft-Hansen H., Buist R., Sun X.J., Schellenberg A., Peeling J., Owens T. Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system. J.Immunol. 2006, 177:7242-7249.
39. Tran E.H., Prince E.N., Owens T. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J.Immunol. 2000, 164:2759-2768.
40. Van den Steen P.E., Proost P., Wuyts A., Van Damme J., Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 2000, 96:2673-2681.
41. Van den Steen P.E., Husson S.J., Proost P., Van Damme J., Opdenakker G. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem. Biophys. Res. Commun. 2003, 310:889-896.
42. van Loo G., De Lorenzi R., Schmidt H., Huth M., Mildner A., Schmidt-Supprian M., Lassmann H., Prinz M.R., Pasparakis M. Inhibition of transcription factor NF-kappaB in the central nervous system ameliorates autoimmune encephalomyelitis in mice. Nat. Immunol. 2006, 7:954-961.
43. Vergote D., Butler G.S., Ooms M., Cox J.H., Silva C., Hollenberg M.D., Jhamandas J.H., Overall C.M., Power C. Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proc. Natl. Acad. Sci. USA 2006, 103:19182-19187.
44. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector Tcell lineages. Annu. Rev. Immunol. 2007, 25:821-852.
45. Wu C., Ivars F., Anderson P., Hallmann R., Vestweber D., Nilsson P., Robenek H., Tryggvason K., Song J., Korpos E., et al. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat. Med. 2009, 15:519-527.